Feuille, Colin
Kari, Swathi
Patel, Roshan
Oberoi, Rohan
Liu, Jonathan
Ohliger, Michael
Khalili, Mandana
Tana, Michele
Article History
Received: 1 March 2023
Accepted: 3 January 2024
First Online: 20 January 2024
Competing interests
: Colin Feuille, Swathi Kari, Roshan Patel, Rohan Oberoi, and Michele Tana have no conflicts of interest to disclose. Mandana Khalili is a recipient of research grant (to her institution) from Gilead Sciences Inc and Intercept Pharmaceuticals and she has served as consultant for Gilead Sciences Inc. Michael Ohliger has a research grant (to his institution) from GE Healthcare and has received travel and speaker funds from GE Healthcare. Michele Tana consulted for Merck Inc.